Marc Lalande has been appointed to the new position of executive director of Genomics and Personalized Medicine Programs at the University of Connecticut where he will help lead the development of research and training programs for the Institute of Systems Genomics, collaborations with The Jackson Laboratory for Genomic Medicine, and industry and government partnerships for the planned CT Institute for Medical Innovation and Applied Health Care Economics.
Lalande will also maintain his current positions as the Health Net professor and chairman of the Department of Genetics and Developmental Biology and director of both the University of Connecticut Stem Cell Institute and the Institute for Systems Genomics. He will step down from his position as senior associate dean for research planning and coordination at the UConn School of Medicine.
Genesis Genetics has appointed Tony Gordon to lab director of the company's UK operations and vice president of its US operations. Gordon will sign off all patient reports in the UK and lead the company's efforts to expand testing operations throughout the UK.
Gordon joins Genesis Genetics from BlueGnome. He holds a PhD from Nottingham University.